NASDAQ:HRTX

Heron Therapeutics Stock Forecast

etoro logo Buy HRTX
*Your capital is at risk
$0.476
+0.0370 (+8.43%)
At Close: Jul 16, 2026
AI Analysis AI Analysis of HRTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add HRTX to Watchlist?
Some Reasons Why To Add HRTX:
  • High gross margin of 71.1%
  • Highly efficient cash conversion (103% FCF/OCF ratio)
  • Established player in the Healthcare sector
PDF

Volatile ride for Heron Therapeutics stock price on Thursday moving between $0.430 and $0.495
(Updated on Jul 16, 2026)

Hold candidate since Jul 15, 2026 Gain 8.43%

The Heron Therapeutics stock price gained 8.43% on the last trading day (Thursday, 16th Jul 2026), rising from $0.439 to $0.476. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 15.11% from a day low at $0.430 to a day high of $0.495. The price has risen in 6 of the last 10 days and is up by 12.16% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 5 million shares were bought and sold for approximately $2.61 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.547 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -63.93% during the next 3 months and, with a 90% probability hold a price between $0.0231 and $0.197 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

HRTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 24.61%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Heron Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.478. On a fall, the stock will find some support from the short-term average at $0.436. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Heron Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.450 and $0.447. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Heron Therapeutics finds support just below today's level at $0.450. If this is broken, then the next support from accumulated volume will be at $0.447 and $0.430.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0650 between high and low, or 15.11%. For the last week, the stock has had daily average volatility of 9.37%.

Our recommended stop-loss: $0.449 (-5.62%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 20 days ago.)

Trading Expectations (HRTX) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect Heron Therapeutics to open at $0.467, and during the day (based on 14 day Average True Range), to move between $0.456 and $0.496, which gives a possible trading interval of +/-$0.0400 (+/-8.77%) up or down from last closing price. If Heron Therapeutics takes out the full calculated possible swing range there will be an estimated 8.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.484 (1.58%) than the support at $0.450 (5.46%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Heron Therapeutics stock A Buy?

Heron Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.044 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $0.467 ( 1.88%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

HRTX Performance

Trading levels for HRTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.532 11.78%
R2 0.507 6.56%
R1 0.492 3.34%
Price 0.476
S1 0.442 -7.09%
S2 0.427 -10.32%
S3 0.402 -15.53%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0.484 1.58%
Price 0.476
S1 0.450 -5.46%
S2 0.447 -6.13%
S3 0.430 -9.66%

FAQ

What is the symbol for Heron Therapeutics Stock and on which exchange is it traded?
The symbol for Heron Therapeutics is HRTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Heron Therapeutics Stock?
Heron Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Heron Therapeutics Stock?
Heron Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Heron Therapeutics Stock.

What's the current price of Heron Therapeutics Stock?
As of the end of day on the Jul 16, 2026, the price of an Heron Therapeutics (HRTX) share was $0.476.

What is the 52-week high and low for Heron Therapeutics Stock?
The 52-week high for Heron Therapeutics Stock is $2.10 and the 52-week low is $0.382.

What is the market capitalization of Heron Therapeutics Stock?
As of the Jul 16, 2026, the market capitalization of Heron Therapeutics is 75.179M.

When is the next earnings date for Heron Therapeutics?
The upcoming earnings date for Heron Therapeutics is Aug 14, 2026.
Click to get the best stock tips daily for free!
ABOUT HERON THERAPEUTICS
Heron Therapeutics
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.06% Jul 13
SRPT
$17.02
1.23% Jun 29
NMRK
$15.02
5.86% Jun 24
X
XMAX
$8.34
2.28% Jun 24
JLL
$299.78
12.03% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE